• CO22 Real-World Effectiveness of Alcohol Use Disorder Treatment on Healthcare Utilization and Expenditure Among U.S. Adult Cancer Survivors: A Propensity-Score Matched Cohort Study

    Jul 1, 2025, 00:00

  • MSR146 Identifying Redundant or Misfitting Items Using Item Response Theory: Type I and II Error Rates for Item Local Dependence and Misfit Detection in Clinical Outcome Assessments

    Jul 1, 2025, 00:00

  • CO23 Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Naïve Patients with T2D

    Jul 1, 2025, 00:00

  • HPR64 ICER Thresholds in Cost-Utility Analysis: Assessing Conceptual Relevance and Practical Adequacy for Drug Reimbursement Decision-Making in The US

    Jul 1, 2025, 00:00

  • P62 Characteristics of RWE used in Regulatory Decision-Making for Marketing Authorization Applications (MAAs)

    Jul 1, 2025, 00:00

  • PCR92 Renal Cell Carcinoma and Muscle Invasive Bladder Cancer Patients' Perception of Risk and Fear of Recurrence

    Jul 1, 2025, 00:00

  • RWD169 Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments

    Jul 1, 2025, 00:00

  • PCR9 Empowering Patients in Observational Research: Leveraging Data Insights for Sustained Engagement and Innovation

    Jul 1, 2025, 00:00

  • EPH9 A Retrospective Medical Expenditure Panel Survey Database Study Assessing Factors Associated with Health Status Among United States Adults with Asthma

    Jul 1, 2025, 00:00

  • EE436 Real World Healthcare Resource Utilization (HRU) and Costs Associated With Mantle Cell Lymphoma (MCL) Therapies in the Frontline (1L) and Relapsed/Refractory (R/R) Setting

    Jul 1, 2025, 00:00

  • MSR82 Effectiveness of Activity Criteria in Stabilizing Patient Cohorts in Open Claims Data for Healthcare Outcomes Research

    Jul 1, 2025, 00:00

  • EE410 Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Chronic Lymphocytic Leukemia Treated with Fixed Duration Therapy in a First-Line Setting in Alberta, Canada

    Jul 1, 2025, 00:00

  • EPH61 Algeria's Healthcare System in 2024: Progress Against Persisting Challenges

    Jul 1, 2025, 00:00

  • EE215 Pompe Disease in Sweden: A Real-World Evidence Study Investigating Healthcare Resource Utilisation and Costs

    Jul 1, 2025, 00:00

  • MSR88 Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research

    Jul 1, 2025, 00:00

  • PCR128 Validation of a Questionnaire to Evaluate Simplicity of Diabetes Treatment (SIM-Q)

    Jul 1, 2025, 00:00

  • EE370 The Costs Associated with Healthcare Resource Use and Work Productivity for Care Partners of Multiple Myeloma Patients in the United States and Europe

    Jul 1, 2025, 00:00

  • CO8 Evaluating the Effects of the COVID-19 Pandemic on ICU Mortality and Sedation Charges in Mechanically Ventilated Patients

    Jul 1, 2025, 00:00

  • PCR156 Frequency and Severity of COVID-19 Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Early 2024-2025 Respiratory Season Results of a Nationwide Study

    Jul 1, 2025, 00:00

  • EE294 Economic Burden of Avoidable Blindness Due to Diabetic Macular Edema in Ecuador

    Jul 1, 2025, 00:00

  • RWD58 Concomitant Usage of Contra-Indicated Medications in Patients With Atrial Fibrillation: A Comparison of Real-World Data Sources in the United States

    Jul 1, 2025, 00:00

  • OP8 Framework for Real-World Data Used in Regulatory Submissions

    Jul 1, 2025, 00:00

  • HSD20 An Analysis of Hospitalization Metrics After Intravenous (IV) Ferric Derisomaltose (FDI) versus Usual Care (UC) in Patients with Iron Deficiency Anemia (IDA) and Heart Failure (HF) Based on IRONMAN

    Jul 1, 2025, 00:00

  • HSD19 Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach

    Jul 1, 2025, 00:00

  • RWD157 K2GC: Real-world Treatments and Outcomes Amongst Patients With Resectable Gastric (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States (US)

    Jul 1, 2025, 00:00

  • EPH162 Real-World Demographic and Clinical Characteristics of Patients With Atherosclerotic Cardiovascular Disease With or Without Chronic Kidney Disease or Systemic Inflammation in the United States

    Jul 1, 2025, 00:00

  • OP5 Analysis of the Human Development Index by Innovation In Health, Through the Incorporation of New Technologies In Oncology: Preliminary Data in LMIC/LATAM/Brazil

    Jul 1, 2025, 00:00

  • EPH150 Microbiology Testing and Oral Antibiotic Treatment Among CKD Patients With Urinary Tract Infections: Real-World Evidence From a US EMR Network

    Jul 1, 2025, 00:00

  • PCR216 Predicting Future Type 1 Diabetes Onset Risk; A Machine Learning Approach

    Jul 1, 2025, 00:00

  • MSR75 Comparison of Generative AI and Manual Data Programming in a Lupus Health Productivity Loss Study

    Jul 1, 2025, 00:00

  • EPH23 Epidemiology and Disease Burden of Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, and Systemic Inflammation in Northern China: A Retrospective Study of Tianjin Regional Electronic Health Records

    Jul 1, 2025, 00:00

  • MSR125 Methodology for Estimating Equal Value Life-Year for Standard Three-State Partitioned Survival Models

    Jul 1, 2025, 00:00

  • EPH152 Trends in Cardiovascular and Cancer Mortality Among Texas Residents with Cancer between 2010 and 2019

    Jul 1, 2025, 00:00

  • PCR115 Qualitative Assessment of the Idiopathic Hypersomnia Severity Scale: Suitability for Use As a Clinical Trial Endpoint as Demonstrated in NCT05156047

    Jul 1, 2025, 00:00

  • EPH136 Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database

    Jul 1, 2025, 00:00

  • HPR171 Comparison of Therapeutic Efficacy by Disease for Outpatients Using Herbal Decoctions Based on the Using the Usage and Consumption of Korean Medicine Report in 2020

    Jul 1, 2025, 00:00

  • PT29 Increased Incidence of Parkinson Disease Associated with Antiseizure Medication Use

    Jul 1, 2025, 00:00

  • PCR137 Patient and Physician Perspectives on Attributes of IO-Containing? Perioperative Treatments in Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer (NSCLC)

    Jul 1, 2025, 00:00

  • EE202 Economic Evaluations of Imaging Guidance for Percutaneous Coronary Interventions: A Scoping Review

    Jul 1, 2025, 00:00

  • EE346 The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter

    Jul 1, 2025, 00:00

  • EE481 Budget Impact Analysis of Volanesorsen as a Complement to the Diet in Adult Patients with Familial Chylomicronemia Syndrome (FCS) in Mexico

    Jul 1, 2025, 00:00

  • EPH138 Dynamic Population Modelling Indicates a Flavored EVP Ban in the UK May Negatively Impact Population Health

    Jul 1, 2025, 00:00

  • PCR129 Utility Values From Individuals With Knee Osteoarthritis in the UK

    Jul 1, 2025, 00:00

  • PCR237 Evaluating Thresholds for Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures (PROMs) in Locally Advanced or Metastatic Urothelial Cancer (la/mUC): a Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • HPR82 Real-World Evidence in FDA and EMA Regulatory Reviews: Insights on Its Role in Submission Packages and Approvals

    Jul 1, 2025, 00:00

  • EE305 Cost-Effectiveness of Maribavir for Post-Transplant Refractory (With or Without Resistance) Cytomegalovirus Infection in China

    Jul 1, 2025, 00:00

  • HPR43 Unlocking the Potential of OBRSAs in the US: Insights on Challenges, Policy Changes, and Pathways Forward

    Jul 1, 2025, 00:00

  • MT15 RtCGM Use is Associated with Improved Glycemic Control Compared to isCGM in Commercially Insured People with Type 2 Diabetes on Semaglutide and Insulin

    Jul 1, 2025, 00:00

  • HSD25 Efficacy of Improvisational Communication Training for Health Workers in Emergency Care Unit in Hungary: Quazy Experimental Study

    Jul 1, 2025, 00:00

  • EE354 Impact of Capacity and Resource Constraints on Wet Age-Related Macular Degeneration and Diabetic Macular Edema in the Brazilian Public Healthcare System: an Individual-Level Microsimulation Study

    Jul 1, 2025, 00:00

  • EE463 A Longitudinal Year-by-Year Cost Analysis for Patients Diagnosed with Polycythemia Vera

    Jul 1, 2025, 00:00

  • HPR57 Comparing the Social and Private Value Created by Pembrolizumab 2014-2022

    Jul 1, 2025, 00:00

  • Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report

    Jul 1, 2025, 00:00

  • EE236 A Health Economic Evaluation of an Artificial Intelligence-Assisted Prescription Review System in a Real-World Setting in China

    Jul 1, 2025, 00:00

  • RWD44 Clinical Validation of Large Language Model for Automated Extraction of Genetic Testing Data

    Jul 1, 2025, 00:00

  • P32 Oncology Trial Emulation Using Real-World Electronic Health Record Data: Results of the Coalition to Advance Real-World Evidence Through Randomized Controlled Trial Emulation (CARE) Initiative

    Jul 1, 2025, 00:00

  • MSR65 Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies

    Jul 1, 2025, 00:00

  • PCR98 Enhancing Healthcare Quality through Patient-Centered Outcome Measures in Medicare's Merit-based Incentive Payment System

    Jul 1, 2025, 00:00

  • EE309 Examination of the Two-Year US Commercial Payer Budget Impact (BI) of the Leva Pelvic Health System, a Prescription Medical Device That Provides Supervised Pelvic Floor Muscle Training (PFMT) As First-Line Treatment for Female Urinary ...

    Jul 1, 2025, 00:00

  • Reviewer Acknowledgment

    Jul 1, 2025, 00:00

  • P46 Probabilistic Attribute Presentation in Discrete Choice Experiments (DCEs): A Review of Current Practice

    Jul 1, 2025, 00:00

  • CO79 Estimating the Effect of a Discontinued Amyotrophic Lateral Sclerosis Treatment on Time-to-Death Using Sequential Target Trial Emulation

    Jul 1, 2025, 00:00

  • MSR17 A Comparative Assessment of LLM Agreement for Clinical Data Extraction Tasks

    Jul 1, 2025, 00:00

  • EE337 Economic Burden of Rheumatoid Arthritis in Low- and Middle-Income Countries: Systematic Review

    Jul 1, 2025, 00:00

  • HTA96 Navigating Evidence Requirements for Joint Clinical Assessment of Orphan and Advanced Therapy Medicinal Products in Europe

    Jul 1, 2025, 00:00

  • PCR186 JAV-RARAS: Evaluation of Adherence to Clinical Protocol and Therapeutic Guidelines (PCDT) for Mucopolysaccharidosis Type 2 (MPS2) at Codajás Polyclinic - An Analysis of the Value-Based Care Journey

    Jul 1, 2025, 00:00

  • CO5 Patient Journey Prior to the Diagnosis of Niemann-Pick Disease Type C

    Jul 1, 2025, 00:00

  • EPH111 Epidemiology of Polymyalgia Rheumatica: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • RWD166 Use of a Representative Sample of the French National Health Insurance Database (ESND) for Research: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE511 Descriptive Analysis Of Patients With Psoriasis (PSO) Using Biologics Vs. Non-biologics

    Jul 1, 2025, 00:00

  • MT27 Impact of Single-Patient use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in the USA

    Jul 1, 2025, 00:00

  • HPR92 Evolution of Technology Diffusion within Brazilian Universal Healthcare System (Sistema Único de Saúde - SUS) 2+ Years After Listing of Antiangiogenics Treatment for Age-Related Macular Edema (AMD)

    Jul 1, 2025, 00:00

  • EE230 The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in Canada

    Jul 1, 2025, 00:00

  • EPH171 Gabapentinoid Use, Potential Misuse, and Associated Risk Factors among U.S. Adult Cancer Survivors: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • A Scoping Review of Interventions to Reduce the Environmental Footprint of Healthcare

    Jul 1, 2025, 00:00

  • HSD26 Cancer Survivors and Opioid Use During Survivorship - A Scoping Review

    Jul 1, 2025, 00:00

  • EPH186 Temporal Trends in Emergency Department Utilization for Opioid Use Disorder in Baltimore, Maryland

    Jul 1, 2025, 00:00

  • HPR99 Racial and Ethnic Disparities in Orphan Drug Utilization Among Medicare Beneficiaries

    Jul 1, 2025, 00:00

  • MSR136 Augmenting Race and Ethnicity in a Real-World Oncology Cohort Using the Bayesian Improved Surname Geocoding Methodology

    Jul 1, 2025, 00:00

  • MSR42 Three Different Methods to Estimate a Rare Disease (RD) Prevalence in a Country with a Limited Dataset: Which One Fits?

    Jul 1, 2025, 00:00

  • RWD60 Evaluating Electronic Data Network and Direct Facility Retrieval Data Sources for Improved Patient Record Capture in Observational Studies

    Jul 1, 2025, 00:00

  • PCR13 Content Validation of the Patient Attainment Scale-Essential Tremor (PAS-ET): A Novel Patient-Reported Outcome Measure Assessing Patient-Level Perceptions of the Importance, Current Function and Definitions of Meaningful Improvement i ...

    Jul 1, 2025, 00:00

  • EE351 Cost-Utility Analysis of Sequential Therapy of iCT IRd and DRd strategy for Newly Diagnosed Multiple Myeloma Patients Who are Transplant-Ineligible in China

    Jul 1, 2025, 00:00

  • HPR112 Impact of New Cervical Cancer Screening Program Using Human Papillomavirus (HPV) Deoxyribonucleic Acid (DNA) Testing on Urban-Rural Disparities in Thailand: A Post-Hoc Distributional Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • HPR23 The Most Heavily Managed Drug Categories on Part D Formularies

    Jul 1, 2025, 00:00

  • CO55 A Retrospective Real-World Data Analysis of Pregnancy Outcomes Among Women with a History of Hysteroscopic Intrauterine Adhesiolysis (HA), Other Intrauterine Surgery (IUs), or no Prior IUs

    Jul 1, 2025, 00:00

  • MT39 Real-World Clinical Outcomes, Healthcare Resource Utilization, and Direct Medical Costs in Atrial Fibrillation Patients Receiving Catheter Ablation in Japan

    Jul 1, 2025, 00:00

  • CO77 External Control Arm With Real World Data to Assess the Effect of Semaglutide on Chronic Kidney Disease Risk Among Patients With Type 2 Diabetes

    Jul 1, 2025, 00:00

  • HTA94 Investing in Clinical Guidelines to Enhance Health Technology Assessments and Reimbursement Decisions

    Jul 1, 2025, 00:00

  • HSD2 Cognitive Impairment at Initial Diagnosis of Alzheimer’s Disease: Patient Characteristics and Treatments in the Real-World Setting

    Jul 1, 2025, 00:00

  • HPR8 Healthcare Across Borders: Changes in Physician Numbers and Spatial Inequalities in Hungary and the DACH Countries (Austria, Germany, Switzerland)

    Jul 1, 2025, 00:00

  • P49 A Health Technology Assessment Framework for Ethics Analysis in Drug Reimbursement Reviews at Canada's Drug Agency

    Jul 1, 2025, 00:00

  • HSD51 Premature Treatment Discontinuation Among Previously Untreated Medicare Beneficiaries With Chronic Lymphocytic Leukemia Treated With Oral Targeted Therapies: A Real-World Analysis

    Jul 1, 2025, 00:00

  • RWD24 Optimizing EHR Data Completeness: A Conceptual Framework for Bringing Real-World Data into Clinical Research through Relevant Completeness

    Jul 1, 2025, 00:00

  • PCR57 Investigating the Potential of Extracting Answers to Health-Related Quality of Life Questionnaires From Patient Community Data

    Jul 1, 2025, 00:00

  • EE376 Treatment Patterns and Healthcare Resource Utilization of Patients Early in Schizophrenia Illness Initiating Aripiprazole Lauroxil Versus Oral Aripiprazole: A Retrospective Claims-Based Study

    Jul 1, 2025, 00:00

  • MT12 Patient-Centric Factors in AI Chatbot Adoption for Healthcare

    Jul 1, 2025, 00:00

  • EPH47 Characteristics Correlated with Limited Physical Functioning in US Adults with Arthritis: A Cross-Sectional Database Analysis of the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • CO49 Prognostic or Predictive Factors in Biliary Tract Cancer: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • EPH101 National Respiratory Surge Forecasting With Combined Pharmacy and Public Health Data

    Jul 1, 2025, 00:00

  • PCR97 Recurrent Patient-Reported Outcome (PRO)-Based Symptomatic Deterioration Predicts Survival and Disease Progression in Patients With Resectable Non-Small Cell Lung Cancer (NSCLC): Post-Hoc Analysis of RATIONALE-315

    Jul 1, 2025, 00:00

  • PCR30 Perfect Health Reporting on EQ-5D-5L: The Role of Personal, Family and Social Network Illness Experiences

    Jul 1, 2025, 00:00

  • RWD55 A Large Language Model Approach for Evaluating Real-World Evidence in FDA Approvals

    Jul 1, 2025, 00:00

  • MSR97 An “R-Shiny” Interface Designed As a One-Stop Solution for All Kinds of Indirect Treatment Comparisons According to NICE Technical Support Documents 2, 3, and 18

    Jul 1, 2025, 00:00

  • EE248 Healthcare Resource Utilization of Adult Patients with Obesity Before vs. After GLP-1 Treatment in the United States Elective Outpatient Setting

    Jul 1, 2025, 00:00

  • HSD106 Assessing Infection Prevention Staffing and Resource Allocation Across Single and Multi-Facility Hospitals: A Comparative Analysis

    Jul 1, 2025, 00:00

  • EE522 Long-Term Cost-Effectiveness Analysis of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogues in Patients With Type 2 Diabetes in China

    Jul 1, 2025, 00:00

  • HPR83 China's National Reimbursement Drug List (NRDL) Negotiation: Value Considerations and Key Factors Influencing Payment Standards

    Jul 1, 2025, 00:00

  • HTA15 Da Vinci Robotic-Assisted Surgery: 5 years of Health Technology Assessment Trends and Recommendations

    Jul 1, 2025, 00:00

  • RWD34 Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities

    Jul 1, 2025, 00:00

  • HTA78 Assessing the Acceptance of Single-Arm Trials in Health Technology Appraisals: A Review of NICE, CADTH, HAS, and NCPE Appraisals in 2024

    Jul 1, 2025, 00:00

  • EE344 Evaluating the Budget Impact of an Intrauterine Device for Postpartum Hemorrhage Management: A Hospital Perspective

    Jul 1, 2025, 00:00

  • MSR79 The Impact of Prior Choice for Between-Study Heterogeneity in Network Meta-Analysis on Model Conclusions

    Jul 1, 2025, 00:00

  • PCR177 Patient-Reported Outcomes in Indirect Treatment Comparisons: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EPH43 The Association Between COVID-19 Vaccination History and the Incidence of COVID-19 and Healthcare Resource Use in Rural Residents in Japan

    Jul 1, 2025, 00:00

  • HPR96 The Changing Impact of the Inflation Reduction Act on Payer Utilization Management- Insights from an Ongoing Quantitative Survey

    Jul 1, 2025, 00:00

  • EPH56 Real-World Demographics and Clinical Characteristics of Multiple Myeloma Patients in a Colombian HMO During 2015-2023

    Jul 1, 2025, 00:00

  • EPH12 Estimating Epidemiological Estimates of Rare Diseases in Reimbursement Submissions to Canada's Drug Agency: A Comparison of Approaches in the Absence of Local Real-World Data

    Jul 1, 2025, 00:00

  • PCR101 Association of Chronic Conditions and Medication Burden with Patient Preferences for Long-Acting Antiretroviral Therapy in HIV Treatment

    Jul 1, 2025, 00:00

  • EPH59 Application of Prevalent New-User Cohort Designs to a Claims Data Study of Incidence of Nutritional Deficiency in People With Diabetes Using GLP-1 Receptor Agonists

    Jul 1, 2025, 00:00

  • MSR69 Emerging Trends in AI Applications: Shaping Pharmacoepidemiology and Health Technology Assessments

    Jul 1, 2025, 00:00

  • MSR51 Maximizing the Impact of In-Trial Interviews Through AI Assisted Analysis

    Jul 1, 2025, 00:00

  • HPR147 Ongoing Accelerated Approval Trends and What It Means for Patients

    Jul 1, 2025, 00:00

  • PT14 Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies

    Jul 1, 2025, 00:00

  • HSD82 Prisoners’ Preferences for Virtual Care Design and Delivery in the Correctional Setting: A Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • RWD171 Baseline BMI and HbA1c Trends in US Diabetic Patients Initiating GLP-1 Therapy: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • MSR143 Developing a Large Language Model-Based Simulation for PT Committees: Methodology and Inputs for Realistic Dynamics

    Jul 1, 2025, 00:00

  • HSD99 Geographic Inequities in Bariatric Surgery Access in Southern Chile: The Case of the Chilean Bundled Payment PAD

    Jul 1, 2025, 00:00

  • PT37 Operationalizing an Outcomes-Based MarketAccess Agreement Using Real-World Data From the Canadian Neuromuscular Disease Registry

    Jul 1, 2025, 00:00

  • EE408 Healthcare Resource Utilization And Costs Following Disease Progression With First-Line Systemic Therapy In Patients With Advanced Endometrial Cancer in the US

    Jul 1, 2025, 00:00

  • PCR205 What Is the Level of Agreement between Family Caregivers and Their Children Living with Rheumatic Disease in Reporting Health-Related Quality of Life?

    Jul 1, 2025, 00:00

  • EPH74 Characteristics of Patients Initiating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists (RAs) for Cardiometabolic Risk Reduction in a Medicare Population

    Jul 1, 2025, 00:00

  • HPR33 Consumption and Expenditure of WHO Essential Medicines for Cancer: Drug Utilization Analysis of 40 Countries and Regions from 2012 to 2022

    Jul 1, 2025, 00:00

  • EPH48 Variables Statistically Associated With Mental Health Among United States Adults With Asthma in the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • P18 Disparities in Antipsychotic Prescribing Among the US Medicare Population

    Jul 1, 2025, 00:00

  • The Argument-Based Approach to Validity Applied to Clinical Outcome Assessments: Some History and Notable Features

    Jul 1, 2025, 00:00

  • EE222 Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico

    Jul 1, 2025, 00:00

  • CO1 Assessment of Disease Progression and Healthcare Resource Utilization Associated with Duchenne Muscular Dystrophy: A Retrospective Observational Study Using the Optum Market Clarity Database

    Jul 1, 2025, 00:00

  • EE348 A Systematic Review of Economic Evaluations of Healthcare Associated Infection Prevention and Control Interventions in Long Term Care Facilities

    Jul 1, 2025, 00:00

  • EPH24 Sodium Glucose Co-Transporter 2 Inhibitor Exposure and the Risk of Congenital Malformations: Nationwide Birth Cohort Study

    Jul 1, 2025, 00:00

  • HPR37 Navigating the IRA: Impact of Medicare Part B Rebates on Drug Pricing and Manufacturer Strategies

    Jul 1, 2025, 00:00

  • PCR253 Psychometric Evaluation of the ASCOT-SCT4, a Preference-Based Quality of Life Instrument for Social Care Service Users in Hong Kong: An Application of Item Response Theory

    Jul 1, 2025, 00:00

  • HTA46 Fostering the Identification and Dissemination ofHealth Technology Assessment Studies: The Brazilian HTA Database Case Study

    Jul 1, 2025, 00:00

  • EPH116 Informing Blood Donor Safety and Blood Supply Management in the United States: Factors Affecting Donor Time-To Return After Low Hemoglobin Deferral

    Jul 1, 2025, 00:00

  • CO63 Racial Disparities in the Burden of Illness Among Adults with Prostate Cancer in the United States

    Jul 1, 2025, 00:00

  • PT19 Timing of Health Technology Assessment in the United States: An Evaluation of ICER Reviews Over Seven Years

    Jul 1, 2025, 00:00

  • HTA89 Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA

    Jul 1, 2025, 00:00

  • EE389 Cost-Effectiveness of Pembrolizumab as First-Line Treatment for Patients with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Unresectable or Metastatic Colorectal Cancer (CRC) from Public Payer Perspective ...

    Jul 1, 2025, 00:00

  • EPH130 Racial/Ethnic Disparities in Pneumococcal Vaccination Rates Among the Elderly: Trends and Associated Factors in the U.S., 2018-2023

    Jul 1, 2025, 00:00

  • PCR241 Beyond Overall Survival: Advancing the Understanding and Use of Surrogate Endpoints in Oncology

    Jul 1, 2025, 00:00

  • PT3 An Artificial Intelligence (AI)-Assisted Systematic Literature Review (SLR) of the Economic Burden in Metastatic Pancreatic Adenocarcinoma: A Proof-of-Concept Study

    Jul 1, 2025, 00:00

  • HSD16 Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey

    Jul 1, 2025, 00:00

  • CO41 Real-world Clinical And Demographic Characteristics Associated With Progression To Type 2 Diabetes In Patients With Prediabetes

    Jul 1, 2025, 00:00

  • EE299 Cost Per PFS-Based Responder for TKI-Naive Patients Receiving Repotrectinib or Entrectinib in ROS1 Fusion Positive Non-Small Cell Lung Cancer (NSCLC) in the United States (US)

    Jul 1, 2025, 00:00

  • HTA35 Economic Analysis of an Optical Neonatal Skin Maturity Meter (MOMPN) in Brazilian Newborns

    Jul 1, 2025, 00:00

  • HPR39 Health Insurance Use Among Young Pharmacists in Nigeria

    Jul 1, 2025, 00:00

  • MSR73 Augmenting Small Training Datasets Improves Machine Learning Prognostic Performance

    Jul 1, 2025, 00:00

  • RWD80 Presenteeism in Employees with Chronic Conditions: An Analysis Using Linked Claims and Self-Reported Employee Health Risk Assessment Data

    Jul 1, 2025, 00:00

  • HPR91 Perceptions of Private Health Insurance Among Households in a Small Island Developing State (SIDS): The Case of Grenada

    Jul 1, 2025, 00:00

  • SA6 Changes in HbA1c and Body Weight in US Adults With Type 2 Diabetes and Chronic Kidney Disease Who Received Oral Semaglutide

    Jul 1, 2025, 00:00

  • RWD93 Programmed Death Ligand 1 (PD-L1) Protein Expression Among Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma from Two Oncologic Institutions in Brazil

    Jul 1, 2025, 00:00

  • Use of Real-World Data to Support Economic Evaluations of Tumor-Agnostic Therapies: Challenges Remain

    Jul 1, 2025, 00:00

  • CO78 Clinical and Economic Burden of Non-Obstructive Hypertrophic Cardiomyopathy: A Literature Review

    Jul 1, 2025, 00:00

  • EE435 Integration of Environmental Considerations in Economic Evaluations: Significant Shift or Token Gesture? Insights From Severe Asthma Treatments

    Jul 1, 2025, 00:00

  • HTA74 Transforming Global Value Dossier (GVD) Drafting: Creation with a Generative Artificial Intelligence (Gen AI)-Driven Coauthoring Accelerator

    Jul 1, 2025, 00:00

  • HPR65 Early Signals of Inflation Reduction Act Impact on Pharmaceutical Investment and Prioritization Decisions

    Jul 1, 2025, 00:00

  • RWD64 Real-Word Data on Long-Term Outcomes Among Adult Patients With Myopericarditis Related Heart Failure

    Jul 1, 2025, 00:00

  • HSD62 Ten-Year Trends in Potentially Inappropriate Sedative-Hypnotics and Pain Medication Use among Medicare Part D Beneficiaries

    Jul 1, 2025, 00:00

  • HTA50 A Reanalysis of Canada's Drug Agency (CDA) Reports: Do Conclusions from Cost-Effectiveness Analyses Using Quality-Adjusted Life-Years (QALYs) Hold When Evaluating with Equal Value of Life-Years Gained (evLYG)?

    Jul 1, 2025, 00:00

  • EE258 Burden of Systemic Light-Chain (AL) Amyloidosis by Mayo Stage: Results From an Electronic Health Record (EHR) Linked To Claims Analysis

    Jul 1, 2025, 00:00

  • EE272 Healthcare Resource Utilization in Patients with Type 1 Diabetes with or without Prior Type 2 Diabetes Misdiagnosis: A Study in a U.S. Managed Care Population

    Jul 1, 2025, 00:00

  • MSR144 Physician-Augmented AI: Improving Machine Learning-Based Detection of NSCLC and Associated Clinical Indicators

    Jul 1, 2025, 00:00

  • HPR40 Determinants of FDA Review Duration for Novel Therapeutics: Analysis of Regulatory Designations and Product Characteristics

    Jul 1, 2025, 00:00

  • EE485 Economic Evaluations of Preventive Interventions for Self-Harm and Suicide: A Systematic Review

    Jul 1, 2025, 00:00

  • HPR34 Time to Access Trends of Pharmaceutical Products in EU4 and UK (2019-2021)

    Jul 1, 2025, 00:00

  • Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States

    Jul 1, 2025, 00:00

  • HPR52 Digital twins: Hype or Hope for Better Health Outcomes?

    Jul 1, 2025, 00:00

  • EE286 Cost-Effectiveness of NALIRIFOX As a First-Line Treatment for Metastatic Pancreatic Cancer in Taiwan

    Jul 1, 2025, 00:00

  • MSR19 An Open-Source LLM Framework For Transparent Data Extraction From Research Papers

    Jul 1, 2025, 00:00

  • P63 Balancing Innovation and Affordability: Analyzing the Cost of Drugs for Rare Diseases in Canada

    Jul 1, 2025, 00:00

  • HTA7 Use of Health Technology Assessments in Specialty Drug Coverage Decisions by U.S. Commercial Health Plans

    Jul 1, 2025, 00:00

  • HPR20 Collaborations Between Pharma and Digital Health Startups: Advancing Innovation and Reimbursement in Digital Health Technologies

    Jul 1, 2025, 00:00

  • EPH102 Changes in the Prevalence of Diabetes Mellitus in Pregnancy : A Nationwide Analysis From Hungary

    Jul 1, 2025, 00:00

  • CO27 Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in the Front-Line Maintenance Setting for Advanced Ovarian Cancer (OC): A Trial-Level Meta-Analysis

    Jul 1, 2025, 00:00

  • PCR231 Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling

    Jul 1, 2025, 00:00

  • HPR117 Racial Disparities in Biomarker Testing Rate, First-Line (1L) Treatment Patterns and Clinical Outcomes Among Real-World Patients in the United States (US) with Advanced or Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jul 1, 2025, 00:00

  • RWD14 Estimating Healthcare Resource Utilization and Direct Costs of Chronic Myeloid Leukemia in the Brazilian Public Health System

    Jul 1, 2025, 00:00

  • EE255 Economic Impact of Recurrence in High-Risk Early-Stage Estrogen-Receptor Positive (ER+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Breast Cancer (BC)

    Jul 1, 2025, 00:00

  • CO93 Real-World Healthcare Resource Utilization in Patients with Idiopathic Pulmonary Fibrosis initiating Antifibrotic Therapy in the Medicare Fee-For-Service Population

    Jul 1, 2025, 00:00

  • Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making

    Jul 1, 2025, 00:00

  • RWD148 Epidemiological Estimates of Interstitial Lung Diseases in Mexico: A Real-World Data Analysis of 2,591,278 Hospital Discharges From the Ministry of Health

    Jul 1, 2025, 00:00

  • RWD133 Building on ‘Contemporary Practice and Considerations for Real-World Data (RWD) Source Identification and Feasibility Assessment’: Mapping Feasibility Criteria Across 46 Real-World Evidence (RWE) Guidelines

    Jul 1, 2025, 00:00

  • HSD70 Importance of Virtual Access for Mental Health Services: Evidence from ESI Population

    Jul 1, 2025, 00:00

  • CO62 Comparison of Central Venous Access Device Insertion Proportions, Costs and Removal Time Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Early Breast Cancer Patients

    Jul 1, 2025, 00:00

  • EE241 Cost-Savings of Primary Healthcare Nurse Practitioners' Planned Interventions for Reducing Transfers of Patients from Home Care to Emergency Departments in Quebec, Canada

    Jul 1, 2025, 00:00

  • HPR51 Real-World Evidence in FDA Approvals for Labeling Extension of Drugs and Biologics

    Jul 1, 2025, 00:00

  • P55 Access to Care and Ability to Afford Prescription and Medical Treatment Among Adults With Obesity in the United States

    Jul 1, 2025, 00:00

  • CO95 Comparative Efficacy, Safety, and Tolerability of Xanomeline and Trospium Chloride versus Eight Atypical Antipsychotics for the Acute Treatment of Adults with Schizophrenia - A Network Meta-Analysis

    Jul 1, 2025, 00:00

  • MSR94 To Bootstrap, or Not to Bootstrap Before Multiple Imputation: That Is the Question

    Jul 1, 2025, 00:00

  • HSD111 Provider perspectives on the DREAMM-7 Trial Results and Belantamab Mafodotin (belamaf) in Combination with Bortezomib and Dexamethasone (B-Vd) as a Potential Treatment for Patients with Relapsed or Refractory Multiple Myeloma (R/R MM ...

    Jul 1, 2025, 00:00

  • PCR45 Rethinking Women's Health: Unpacking the 2024 Women's Health Research Roadmap With a Landscape Review of Clinical Outcome Assessments (COA), Health Agency Recommendations and Drug Label Claims With COA Related to Women's Health

    Jul 1, 2025, 00:00

  • PT27 Cost-Effectiveness of Delaying Progression of Alzheimer's Disease with Novel Monoclonal Antibodies: A Societal Perspective

    Jul 1, 2025, 00:00

  • PCR198 Evaluating the Influence of User-Complexity on Individual Preferences for Upper Limb Prosthetic Selection: Measurement Tool Development for a Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • HPR98 Long-term Sustainability of National Essential Medicines Policy in Primary Care System in Rural Southwestern China from 2012-2017: Discrepancies by Facilities and Medicines

    Jul 1, 2025, 00:00

  • MSR126 Data-Based Lumping and Splitting of Treatments in Network Meta-Analysis in the Presence of Heterogeneity: A Flexible Non-Parametric Bayesian Approach

    Jul 1, 2025, 00:00

  • PCR163 Effectiveness of Co-Creation Physical Literacy Intervention on Weight Control and Physical Fitness Among Obese Children: A PreliminaryInvestigation

    Jul 1, 2025, 00:00

  • RWD10 Characterizing Cardiovascular Disease Patients in US Community Hospitals Using InsightsDB

    Jul 1, 2025, 00:00

  • HTA2 Role of Relative Dose Intensity in Health Economic Evaluations: A Review of National Institute for Health and Care Excellence Technology Appraisals of Treatments in Solid Tumors

    Jul 1, 2025, 00:00

  • MSR104 Revolutionizing Multi-Level Network Meta-Regression: Advancing Analysis With the Package

    Jul 1, 2025, 00:00

  • HTA88 What's Cost Got To Do With It? A Review of Key Issues Related to Costs in Health Technology Assessments in Non-Small-Cell Lung Cancer

    Jul 1, 2025, 00:00

  • MSR38 GenAI Goes to ISPOR: Exploratory, Descriptive Analysis of Generative AI Performance for Summarizing and Synthesizing ISPOR Research Abstracts as Sources

    Jul 1, 2025, 00:00

  • PCR218 Content Validation of the Most Bothersome Symptom - Essential Tremor Questionnaire (MBS-ET): A Cognitive Debriefing Study

    Jul 1, 2025, 00:00

  • MSR21 Do Lifetables Overestimate Non-Cancer-Specific Survival (NCSS) in Oncology? A Case Study From Treatment-Naïve Advanced Melanoma

    Jul 1, 2025, 00:00

  • PCR136 Consumer and Healthcare Provided Preferences for Adult Combination COVID-19 and Influenza Vaccines: Results from a Discrete Choice Study in France, Italy and Germany

    Jul 1, 2025, 00:00

  • PCR230 Patient-Reported Outcomes From a Phase 3 Study of Givinostat in Patients With Duchenne Muscular Dystrophy

    Jul 1, 2025, 00:00

  • EE333 A Budget Impact Analysis of Introducing OPSYNVI for the Treatment of Adult Patients Diagnosed With Pulmonary Arterial Hypertension

    Jul 1, 2025, 00:00

  • RWD144 Travel Burden of Beta-Thalassemia Patients Receiving Red Blood Cell Transfusions in the Brazilian Public Healthcare System: A Real-World Study

    Jul 1, 2025, 00:00

  • PCR53 Redesigning the Care Process to Improve the Experience of Patients with Multiple Sclerosis Throughout the Patient Journey. EMpodera

    Jul 1, 2025, 00:00

  • CO70 Cannabinoids for Symptom Management in Children and Adolescents with Autism Spectrum Disorder: A systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • HTA59 Revisiting Archetypes: New Archetypes for Strategic Global Value Evidence Planning

    Jul 1, 2025, 00:00

  • PCR211 Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and Its Treatment: Concept Elicitation

    Jul 1, 2025, 00:00

  • MSR3 Parametric Model Selection: Beyond AIC/BIC in Health Economic Context

    Jul 1, 2025, 00:00

  • EPH85 Real-World Temporal and Indication-Specific Variation in Drivers of GLP-1 RA Discontinuation

    Jul 1, 2025, 00:00

  • HTA28 Health Equity and HTA: Is Equity Data Shaping Recommendations

    Jul 1, 2025, 00:00

  • EPH2 National Assessment of Breast and Cervical Cancer Screening Using National Health Interview Survey

    Jul 1, 2025, 00:00

  • Psychometric Evaluation of the Proxy-Reported Pediatric Quality of Life Inventory Generic Core Scales Across the Childhood Lifespan in Australian Children and Adolescents With Specified Health Conditions

    Jul 1, 2025, 00:00

  • MSR33 Automated Extraction of Kaplan-Meier Survival Curves Using Generative Artificial Intelligence and Computer Vision

    Jul 1, 2025, 00:00

  • MT21 A New-to-Market Single-Use Ureteroscope: Urologist Performance Rating and Capability Assessment

    Jul 1, 2025, 00:00

  • CO90 What Does the Pan-Asian Evidence for Malignant Robotic-Assisted Procedures With da Vinci Surgical Systems Say? A systematic Literature Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • HPR139 Understanding Japanese Subsidy Initiatives for Rare, Intractable Diseases

    Jul 1, 2025, 00:00

  • PCR69 Examination of Factors Influencing Colorectal Screening Participation

    Jul 1, 2025, 00:00

  • MT38 Does a Digital Health Program Influence One’s Choice of Traditional Health Care? Changes in Health Care Use and Episodic Cost Among a Group of Chronic MSK Patients in a Digital Conservative Musculoskeletal Care Program

    Jul 1, 2025, 00:00

  • EE398 Cost Comparison of Osimertinib Plus Chemotherapy Versus Amivantamab Plus Lazertinib for the First-Line Treatment of Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC

    Jul 1, 2025, 00:00

  • EE437 Out-of-Pocket Health Care Spending Among Medicare Beneficiaries Before and During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • P26 VBA and R to Automate Health Economic Model Programming

    Jul 1, 2025, 00:00

  • EE438 Budget Impact Analysis of Lanadelumab Versus C1 Inhibitor for Hereditary Angioedema Long Term Prophylaxis: A Brazilian Private Sector Perspective

    Jul 1, 2025, 00:00

  • EPH8 Natural History and Burden of Disease Among Patients With Juvenile GM2 Gangliosidoses in France

    Jul 1, 2025, 00:00

  • EPH19 Changes in Respiratory Medication and Antibiotic Use Among Asthma and COPD Individuals During the Pandemic

    Jul 1, 2025, 00:00

  • PCR24 Impact of Herpes Zoster Ophthalmicus on Healthcare Utilization and Patient Reported Outcomes: Results from a Multicenter Cohort Study

    Jul 1, 2025, 00:00

  • EE474 Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Guatemala

    Jul 1, 2025, 00:00

  • EPH154 Racial Differences in Health Status Among Newly Diagnosed Type 2 Diabetes

    Jul 1, 2025, 00:00

  • PCR154 Information-seekingbehavior of the Hungarian population regarding colorectal cancer: A Digital Epidemiological Study Using Google TrendsTM

    Jul 1, 2025, 00:00

  • HSD87 Chimeric Antigen Receptor T Cell (CAR T) Therapy As Second-Line (2L) Treatment for Patients With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Therapy Choice and Treatment Barriers Among US Oncologists

    Jul 1, 2025, 00:00

  • PCR251 Is There Value in Knowing? Perspectives of Cancer Screening Outcomes Among the US General Population

    Jul 1, 2025, 00:00

  • MSR153 Frequently Asked Questions (FAQs): What Are the Risks and Mitigation Strategies in Using Gen-AI in HEOR?

    Jul 1, 2025, 00:00

  • EPH29 Prevalence of Claims-Reported Pruritus in Patients With Primary Biliary Cholangitis Overall and Among Those Treated With Obeticholic Acid

    Jul 1, 2025, 00:00

  • PCR71 Insights from a Shared-Decision Making Appointment Preparation Process in an Eczema Self-Monitoring Mobile Health App

    Jul 1, 2025, 00:00

  • PCR153 The Vaccine Activation Measure (VAM™): Validation of a New Segmentation Tool for Understanding Vaccine Hesitance and Confidence

    Jul 1, 2025, 00:00

  • RWD53 Burden of Illness and Healthcare Resource Utilization (HCRU) for Chronic Obstructive Pulmonary Disease (COPD) in Ontario, Canada

    Jul 1, 2025, 00:00

  • PCR202 An Interim Analysis of the Burden of Influenza Infection on Health-Related Quality of Life and Work Productivity Among Adults in the United States

    Jul 1, 2025, 00:00

  • CO16 The Impact of Glucocorticoid (GC) Dose on Clinical Outcomes in Congenital Adrenal Hyperplasia (CAH): A Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • PT16 Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges

    Jul 1, 2025, 00:00

  • PCR56 Translation and Cultural Adaptation of the Pain Impact Questionnaire (PIQ-6) Among Chronic Pain Patients in Japan

    Jul 1, 2025, 00:00

  • PCR66 Understanding the Caregiver Experience Through an Exploration of the Literature

    Jul 1, 2025, 00:00

  • OP9 Budget Impact Model of Enhanced Lung Cancer Screening With AI/ML Tech-Based Software as a Medical Device (SaMD) on a US Cohort and Private Payer Perspective

    Jul 1, 2025, 00:00

  • EE330 Correlation Between Price and Prevalence in Non-Oncology Orphan Products With Recent Trends (2015-2024)

    Jul 1, 2025, 00:00

  • PCR130 Health-Related Quality of Life (HRQoL) of Large B-cell Lymphoma (LBCL) and Follicular Lymphoma (FL) Patients Treated with Axicabtagene Ciloleucel (Axi-cel) in Clinical Trials and the Real-World: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EE494 Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China

    Jul 1, 2025, 00:00

  • EE270 Cost-Effectiveness Analysis of Tisagenlecleucel for Third-Line Treatment With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients

    Jul 1, 2025, 00:00

  • RWD170 The Pen That Makes You Leaner: GLP-1 Prescription Trends for Weight Loss in the US

    Jul 1, 2025, 00:00

  • EE280 Clinical and Economic Analysis in Rheumatoid Arthritis Treatment: A Managed Care Experience

    Jul 1, 2025, 00:00

  • PT26 Cost-Effectiveness Analysis of Sunvozertinib as a Second-line Treatment for Advanced Non-Small Cell Lung Cancer with EGFR exon20ins Mutation: An Economic Evaluation Based on MAIC

    Jul 1, 2025, 00:00

  • CO40 Real-World Patient Characteristics and Treatment Patterns in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Long-Term Survivorship

    Jul 1, 2025, 00:00

  • EE391 Investing in Optimized HIV Prevention Among Young Men Who Have Sex With Men in Brazil: Insights From Fiscal Health Modeling

    Jul 1, 2025, 00:00

  • MT16 Economic Impact of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants

    Jul 1, 2025, 00:00

  • MSR99 Leveraging Social Media Listening and AI: Topic Modeling and RAG Approaches to Analyse Pet Owners' Perspectives on Nonsteroidal Anti-Inflammatory Drugs in Animal Health

    Jul 1, 2025, 00:00

  • HTA13 Analysis of Reimbursement Outcomes for Oncology Therapies in Quebec, Canada

    Jul 1, 2025, 00:00

  • HTA14 Empowering Healthcare Decision-Making: Leveraging Standardized Template for Enhanced Reliability and Efficiency in Budget Impact Analysis by Health Technology Assessment Agency

    Jul 1, 2025, 00:00

  • HPR110 Racial Disparities and the Impact of Access Restrictions to Apixaban in Part D

    Jul 1, 2025, 00:00

  • MSR68 Development of a Discrete-Time-Updating Algorithm to Predict Cannabis Use Disorder Among Arkansas Medical Marijuana Cardholders

    Jul 1, 2025, 00:00

  • RWD7 Youth Mental Health Crisis: Economic Impacts and HEOR Opportunities

    Jul 1, 2025, 00:00

  • EE216 Health and Economic Impact Analysis of Uncontrolled Hemophilia Patients in Colombia

    Jul 1, 2025, 00:00

  • HPR154 The Impact of the Inflation Reduction Act on Rare Diseases and Orphan Drugs

    Jul 1, 2025, 00:00

  • PCR27 Transcultural adaptation of the NutriQoL® questionnaire in American English

    Jul 1, 2025, 00:00

  • EPH31 Prevalence of Hypertension Over (Calendar) Time Among People With Narcolepsy Treated With Oxybate

    Jul 1, 2025, 00:00

  • PCR245 Inclusion of Health-Related Quality of Life (HRQoL) and Other Patient-Reported Outcomes (PROs) in the United States Food and Drug Administration (FDA) Labels

    Jul 1, 2025, 00:00

  • PCR149 Patient Optimism and the Trade-Off Between Kidney Quality and Waiting Time

    Jul 1, 2025, 00:00

  • EE235 Assessing Risdiplam Cost-Effectiveness for Spinal Muscular Atrophy Types I, II, and III in Chile

    Jul 1, 2025, 00:00

  • EE231 The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in the UK

    Jul 1, 2025, 00:00

  • EE240 Economic Impact of Blister-Packaging on Medication Adherence in First-Line Multiple Myeloma Treatment

    Jul 1, 2025, 00:00

  • HTA64 Validation of Artificial Intelligence (AI) Tool to Identify PICO Questions for EU Joint Clinical Assessment (JCA)

    Jul 1, 2025, 00:00

  • RWD56 Hospitalization Risk Among Adults With Atopic Dermatitis in Brazil's Public Health System

    Jul 1, 2025, 00:00

  • EPH139 How is Patient Safety Addressed in Pharmacy Degree Programs in Brazil?

    Jul 1, 2025, 00:00

  • P56 Biosimilar Optimization in Community Oncology Practices

    Jul 1, 2025, 00:00

  • EE414 Impact Analysis of Statin Discontinuation on Healthcare Resource Utilization (HCRU) and Cost of Care in Patients With Atherosclerotic Cardiovascular Disease (ASCVD) in the US

    Jul 1, 2025, 00:00

  • EPH13 Exploring Anemia and the Underdiagnosis of Myelofibrosis: Findings From a Real-World Retrospective Cohort

    Jul 1, 2025, 00:00

  • PT24 A Quantitative Exploration of Challenges to the Sustainability of the United States Biosimilar Market

    Jul 1, 2025, 00:00

  • MSR46 Evaluation of Machine Learning Assisted Title and Abstract Screening in 5 Clinical Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • PCR44 Characterizing the Experience of Excessive Daytime Sleepiness in Patients with Idiopathic Hypersomnia: Implications for Measuring Daytime Sleepiness with the Epworth Sleepiness Scale in a Clinical Trial (NCT05156047)

    Jul 1, 2025, 00:00

  • HTA18 The Utilization of Qualitative Evidence Synthesis in Brazil’s Public Health System: A Qualitative Analysis

    Jul 1, 2025, 00:00

  • MT17 Digital Health Interventions and Environmental Sustainability: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HSD37 Characteristics of Patients Enrolled in a Pharmacist Managed Rare Disease Program: Highlighting National Diversity and Representation

    Jul 1, 2025, 00:00

  • HSD104 Colorectal Cancer Screening Initiation Among Newly Age-Eligible Medicaid-Insured Individuals in Texas

    Jul 1, 2025, 00:00

  • HSD44 Cost of Depression Related Mental Healthcare for Youth During the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • MSR74 Data Extraction from Full-Text PDFs Using Large Language Models for Systematic Reviews

    Jul 1, 2025, 00:00

  • PCR6 Impacts of Annual Wage on Insulin Adherence in Diabetes

    Jul 1, 2025, 00:00

  • EE322 Cost and Clinical Characteristics of Acute Pancreatitis Hospitalizations Related and Unrelated to Hypertriglyceridemia

    Jul 1, 2025, 00:00

  • PCR8 Application of Sentiment Analysis to Aid in Evaluation of Patient Reported Outcome Measures: Analysis of Qualitative Cognitive Debriefing Interviews

    Jul 1, 2025, 00:00

  • HSD65 Telehealth Use Among Adultswith Sickle Cell Disease in Texas Medicaid Before and During the Covid-19 Pandemic

    Jul 1, 2025, 00:00

  • HTA44 Reimbursement Outcomes for EMA Conditionally Authorized Orphan Drugs (2022-2023): Implications for Joint Clinical Assessment Requirements

    Jul 1, 2025, 00:00

  • RWD18 Treatment Patterns and Healthcare Resource Utilization in Patients Diagnosed With CRSwNP in HMO From Colombia: A Real Word Evidence Study

    Jul 1, 2025, 00:00

  • HTA82 Use of Real-World Evidence in HTA Submissions and Cost-Effectiveness Evaluations in Asia

    Jul 1, 2025, 00:00

  • RWD103 Real-World Biologic Prescribing Patterns and Reasons for Discontinuation in Patients with UC and CD

    Jul 1, 2025, 00:00

  • EE229 Cost-Effectiveness Analysis of First-Line Tremelimumab Plus Durvalumab Versus Sorafenib in Unresectable Hepatocellular Carcinoma

    Jul 1, 2025, 00:00

  • PCR213 Use of Personalized Migraine Summary Reports in a Symptom Tracking Program to Support Migraine Self-Management

    Jul 1, 2025, 00:00

  • MT26 Evaluating the Economic and Environmental Impact of Reprocessed IPC Sleeves for VTE Prophylaxis: a Cost-Consequence Analysis

    Jul 1, 2025, 00:00

  • PCR258 Humanistic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • RWD106 Cardiovascular Morbidity and Mortality Among ATTR-CM Patients Treated with Tafamidis in the US

    Jul 1, 2025, 00:00

  • EE343 Systematic Literature Review of the Economic Burden of Illness in Advanced or Metastatic Non-Small Cell Lung Cancer in First-Line

    Jul 1, 2025, 00:00

  • EE434 An Economic Model to Estimate Costs of Adverse Events in Patients Treated With Lisocabtagene Maraleucel (liso-cel), Axicabtagene Ciloleucel (axi-cel), or Tisagenlecleucel (tisa-cel) for Relapsed/Refractory Follicular Lymphoma

    Jul 1, 2025, 00:00

  • EE472 Cost-effectiveness Analysis of Ferric Carboxymaltose (Renegy®) for the Treatment of Iron Deficiency Anemia During Pregnancy: The Mexican Social Security Institute (IMSS) Perspective

    Jul 1, 2025, 00:00

  • HTA8 Trends in Indirect Treatment Comparison (ITC) Methods Used in Reimbursement Submissions in Canada and the US

    Jul 1, 2025, 00:00

  • HTA12 Navigating Uncertainty in Overall Survival Data: Insights from Positive Canadian HTAs on Lung Cancer Therapies

    Jul 1, 2025, 00:00

  • CO94 Impact of Individualized Neoantigen Therapies on Health, Productivity and Health System Capacity Outcomes in Resectable Melanoma in England

    Jul 1, 2025, 00:00

  • PCR21 Health-Related Quality of Life and Associated Factors Among Patients With Chronic Diseases in Hainan Province, China

    Jul 1, 2025, 00:00

  • RWD13 Real-World Use of Biologics in the Treatment of Psoriasis and Ankylosing Spondylitis in China: The Case of Secukinumab

    Jul 1, 2025, 00:00

  • HTA26 The Impact of CDA-AMC Sequential Analysis on Decision-Making in Oncology

    Jul 1, 2025, 00:00

  • EPH62 Estimation of Treatment Eligible Patients With Transthyretin Cardiac Amyloidosis Within a Health Plan

    Jul 1, 2025, 00:00

  • EE338 Avoidable Costs by the Inclusion Ff Finerenone in Terms of Hospitalization Due to Heart Failure (HF) and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia

    Jul 1, 2025, 00:00

  • HSD110 Real-World Subcutaneous Monoclonal Antibody Use Trends for Oncology in the US

    Jul 1, 2025, 00:00

  • EPH187 Association of Sleep Disturbances With Mild Cognitive Impairment Among Adults in the US

    Jul 1, 2025, 00:00

  • PCR23 A Growing Trend: The Expanding Use of Patient-reported Outcome Measures (PROMs) in Clinical Trials (2008-2023)

    Jul 1, 2025, 00:00

  • EE210 Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • P57 Frequency of ICER Miscalculation and Misinterpretation in Published Cost-Effectiveness Analysis Comparing More Than Two Alternatives

    Jul 1, 2025, 00:00

  • HPR42 The Emerging Potential of International Reference Pricing (IRP) in the US: An Analysis of Trends, Challenges, Opportunities and learnings from Europe

    Jul 1, 2025, 00:00

  • RWD101 Epidemiology, Demography and Comorbidities of Patients With Osteoporosis at Very High Risk of Fracture in China

    Jul 1, 2025, 00:00

  • HSD49 Diagnosis and Treatment Journey of Patients With Atrial Fibrillation Prior to Stroke Occurrence

    Jul 1, 2025, 00:00

  • HPR90 Value Communications With US Payers: The Value of Storytelling

    Jul 1, 2025, 00:00

  • EE489 Costs of Initiated Potentially Inappropriate Medication in 2021-2022 in Quebec, Canada

    Jul 1, 2025, 00:00

  • MSR14 Frailty Indices Using Claims Data - Examples from a Hospitalized Medicare Population

    Jul 1, 2025, 00:00

  • MSR140 Adapting PRISMA For System Dynamics Models In Healthcare: A Case Study Of Transcatheter Aortic Valve Implantation In Canada

    Jul 1, 2025, 00:00

  • HSD75 Evaluating the Association Between Medicare Star Ratings Part D Medication Adherence Measures and the Part C Plan All-Cause Readmission Outcome Measure

    Jul 1, 2025, 00:00

  • EPH178 Estimates of the Public Health Impact of Norovirus Vaccination for Older Adults in the United States

    Jul 1, 2025, 00:00

  • CO35 Predicted Effectiveness of First- and Second-Line Treatment Sequences in Advanced or Recurrent Endometrial Cancer

    Jul 1, 2025, 00:00

  • PCR219 Quality-of-Life, Symptom Burden, and Tolerability in Frail Patients without Caregivers in Real-world Oncology Practice

    Jul 1, 2025, 00:00

  • CO67 The Potential Long-Term Comparative Effectiveness of Larotrectinib vs Repotrectinib for Treatment of NTRK Gene Fusion-Positive Cancers

    Jul 1, 2025, 00:00

  • EE327 Belantamab Mafodotin, Pomalidomide, and Dexamethasone (BPd) in Relapsed/Refractory Multiple Myeloma (RRMM): Quality-Adjusted Life-Year (QALY) Results From a Cost-Effectiveness Model

    Jul 1, 2025, 00:00

  • Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses

    Jul 1, 2025, 00:00

  • EE510 An Economic Model to Evaluate the Impact of Formulary Tier Increases for Apixaban on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation in the United States

    Jul 1, 2025, 00:00

  • PCR143 Psychometric Validation of the Modified Low Luminance Questionnaire in Patients With X-Linked Retinitis Pigmentosa

    Jul 1, 2025, 00:00

  • RWD82 Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Bipolar I Disorder

    Jul 1, 2025, 00:00

  • CO44 Comparative Risk of Major Adverse Cardiovascular Events among Patients who Initiate Treatment with Acute Migraine Agents

    Jul 1, 2025, 00:00

  • PCR210 Association Between Caregiver Quality of Life and the Care Provided to Adults With Severe Visual Impairments: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • P22 Assessment of Reasoning Agents for building Literature Search Strategies

    Jul 1, 2025, 00:00

  • RWD49 Development and Application of a Novel Framework for Clinician Stakeholder Engagement in Real-world Data (RWD) Studies

    Jul 1, 2025, 00:00

  • EE267 Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling

    Jul 1, 2025, 00:00

  • PCR99 Mapping between the HUI2/HUI3 and the PROPr in the United States

    Jul 1, 2025, 00:00

  • EPH26 Mortality due to Road Traffic Injuries in Colombia Before and After SARS-CoV-2 (2018-2022)

    Jul 1, 2025, 00:00

  • EE516 Cost-Effectiveness Analysis of Adjuvant Pembrolizumab Versus Standard-of-Care (SOC) Immunotherapies (High-Dose interferon Alfa 2-b or Ipilimumab) in High-Risk Resected Melanoma in United States (US)

    Jul 1, 2025, 00:00

  • HPR67 Canada’s Evolving Market for Biosimilars and What It Means for Payers

    Jul 1, 2025, 00:00

  • HPR47 Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans

    Jul 1, 2025, 00:00

  • HTA29 Who Benefits From Technological Progress Among People With Type 1 Diabetes? Improvements in Glycemic Outcomes After CGM Adoption by Sociodemographic Characteristics

    Jul 1, 2025, 00:00

  • HTA83 Enhancing Health Technology Assessment With Data Transportability Analyses: Addressing Bias and Generalizability Challenges In Non-Local Real-World Evidence

    Jul 1, 2025, 00:00

  • EPH156 Evaluation of Chronic Conditions and Severe Outcomes in Adults Aged 18-59 Years With Medically Attended RSV Illness Using U.S. Commercial Claims Data

    Jul 1, 2025, 00:00

  • PCR19 The Unseen Progress: How PROs May Overlook the Value of Slowing Degenerative Decline

    Jul 1, 2025, 00:00

  • EE374 Cost-Effectiveness Analysis of Dostarlimab Plus Chemotherapy As First-Line Treatment for Metastatic Non-Squamous Non-Small Cell Lung Cancer in Japan

    Jul 1, 2025, 00:00

  • HTA33 Streamlined Success or Missed Opportunity: Evaluating the Impact of Simplified Economic Approaches on HTA Recommendations Across CDA-AMC, INESSS and NICE

    Jul 1, 2025, 00:00

  • EE339 Evaluating the Impact of Predictive Variables on Individual Biosimilar US Market Share

    Jul 1, 2025, 00:00

  • MSR45 Explore the Prognostic Factors of Survival Outcomes in Newly Diagnosed Multiple Myeloma Who Are Not Transplant Eligible

    Jul 1, 2025, 00:00

  • RWD61 Assessing Antipsychotic Adherence in People With Cognitive Impairment Associated With Schizophrenia: A US Non-Interventional Cohort Study of Real-World Data

    Jul 1, 2025, 00:00

  • CO87 Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study

    Jul 1, 2025, 00:00

  • PCR87 Analysis of the Effect of Trofinetide Treatment on the Domain and Item-Level Responses of the Rett Syndrome Behavior Questionnaire Using Data From the LAVENDER Trial

    Jul 1, 2025, 00:00

  • MT7 Latent Class Analysis (LCA) to Identify Medical Device Usage in Real-World Data

    Jul 1, 2025, 00:00

  • EE453 Cost-Effectiveness Analyses of Repotrectinib in TKI-Naïve Patients with ROS1+ Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • PCR118 Real-World Evaluation of Trastuzumab Deruxtecan Administration, Compliance, and Dose Utilization in Chinese Patients With HER2-Positive Advanced Breast Cancer

    Jul 1, 2025, 00:00

  • HPR86 Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis

    Jul 1, 2025, 00:00

  • EPH131 Estimating US Cancer Prevalence With Community Oncology EHR-Based Datasets via National Benchmarks From SEER and NPCR

    Jul 1, 2025, 00:00

  • HPR150 Review of Cell Therapy Access Landscape

    Jul 1, 2025, 00:00

  • SA7 Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data

    Jul 1, 2025, 00:00

  • RWD81 The Economic Burden of Illness for Patients with Idiopathic Pulmonary Fibrosis Utilizing Treatment Cohorts: A US Retrospective Claims Study

    Jul 1, 2025, 00:00

  • EE412 The Economic Impact of Indwelling Urinary Catheterization on Total Joint Arthroplasty Procedures and Implications for Urinary Catheter Alternatives: A Systematic Review, Analysis, and Model

    Jul 1, 2025, 00:00

  • HPR61 US Food and Drug Administration Authorizations of Therapeutic Biologics and Biosimilars, 1980-2024

    Jul 1, 2025, 00:00

  • RWD19 Persistence Patterns of Antidepressants in Mood, Anxiety, and Related Disorders: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • EE250 Quantifying Spillover Impacts: Effect of Novel Therapies for IgA Nephropathy on Patients Awaiting Kidney Transplant

    Jul 1, 2025, 00:00

  • PCR133 Does Providing Informal Care to Alzheimer’s Dementia Cause High Caregiver Burden: Insights From Malaysia

    Jul 1, 2025, 00:00

  • MSR155 Assessing the Effectiveness of Large Language Models in Automating Systematic Literature Reviews: Findings from Recent Studies

    Jul 1, 2025, 00:00

  • EPH107 Patient-Provider Herpes Zoster Vaccination Discussion: Insights From Observed Primary Care Visits in the United States

    Jul 1, 2025, 00:00

  • Editorial Board

    Jun 3, 2025, 09:22

  • Quantifying Low-Value Care in Germany: An Observational Study Using Statutory Health Insurance Data From 2018 to 2021

    Jun 1, 2025, 00:00

  • Use of Real-World Evidence in Health Technology Reassessments Across 6 Health Technology Assessment Agencies

    Jun 1, 2025, 00:00

  • Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices

    Jun 1, 2025, 00:00

  • Understanding the Economic Value of Interventions Addressing Perinatal Mental Health Problems: A Literature Review and Methodological Considerations

    Jun 1, 2025, 00:00

  • Costs and Health Outcomes in Economic Evaluations of Person-Centered Care: A Systematic Review

    Jun 1, 2025, 00:00

  • The Value of Positron Emission Tomography for Confirmation of Alzheimer’s Disease in the Era of Amyloid-Targeting Therapies

    Jun 1, 2025, 00:00

  • Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?

    Jun 1, 2025, 00:00

  • US Drug Pricing Patterns Before Loss of Exclusivity

    Jun 1, 2025, 00:00

  • When Do Value-Based Contracts Add Value? Insights From Probabilistic Simulations

    Jun 1, 2025, 00:00

  • The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level

    Jun 1, 2025, 00:00

  • Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report

    Jun 1, 2025, 00:00

  • Table of Contents

    Jun 1, 2025, 00:00

  • Can Adolescents Value the EQ-5D-Y-5L and EQ-5D-5L, and How Do the Values Compare? A Feasibility Study

    Jun 1, 2025, 00:00

  • A Person-Centered eHealth Intervention for Patients With Common Mental Disorders: Cost-Effectiveness Analysis Within a Randomized Controlled Trial

    Jun 1, 2025, 00:00

  • A Factual Inaccuracy Noted in the Conclusions Specifically Regarding the Novelty of the Author’s Work in the Middle East

    Jun 1, 2025, 00:00

  • Performance of the EQ-5D-5L With Skin Irritation and Self-Confidence Bolt-On Items in Patients With Urticaria

    Jun 1, 2025, 00:00

  • Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations

    Jun 1, 2025, 00:00

  • Drop the “M”: Minimally Important Difference and Change Are Not Independent Properties of an Instrument and Cannot Be Determined as a Single Value Using Statistical Methods

    Jun 1, 2025, 00:00

  • A Managed Access Protocol for Liraglutide for Weight Management: A Retrospective, Observational Study in Ireland

    Jun 1, 2025, 00:00

  • Quality-Adjusted Life Expectancy by Socioeconomic Disadvantage and Remoteness Area: Population Norms for Australia

    Jun 1, 2025, 00:00

  • The Health Inequality Impact of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2025, 00:00

  • Editorial Board

    May 7, 2025, 15:10
  • «
  • 11 (current)
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »